When ctDNA TF is elevated, the sensitivity for driver alterations is increased such that a driver-negative tumor can be distinguished from a sample that merely has low amounts of ctDNA, reducing the need for confirmatory tissue testing in some situations [48]. This evidence concerns the gene TF and neoplasm.